ATE390125T1 - Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe - Google Patents

Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe

Info

Publication number
ATE390125T1
ATE390125T1 AT04757846T AT04757846T ATE390125T1 AT E390125 T1 ATE390125 T1 AT E390125T1 AT 04757846 T AT04757846 T AT 04757846T AT 04757846 T AT04757846 T AT 04757846T AT E390125 T1 ATE390125 T1 AT E390125T1
Authority
AT
Austria
Prior art keywords
hydro
fluoro
formulation
inhaler
propellants
Prior art date
Application number
AT04757846T
Other languages
German (de)
English (en)
Inventor
George Destefano
Linda Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE390125T1 publication Critical patent/ATE390125T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT04757846T 2003-03-20 2004-03-19 Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe ATE390125T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20

Publications (1)

Publication Number Publication Date
ATE390125T1 true ATE390125T1 (de) 2008-04-15

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04757846T ATE390125T1 (de) 2003-03-20 2004-03-19 Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe

Country Status (28)

Country Link
US (1) US7914770B2 (enExample)
EP (1) EP1608336B1 (enExample)
JP (1) JP4708332B2 (enExample)
KR (1) KR101113003B1 (enExample)
CN (1) CN1761455A (enExample)
AT (1) ATE390125T1 (enExample)
AU (1) AU2004224367B2 (enExample)
BR (1) BRPI0408547A (enExample)
CA (1) CA2519523C (enExample)
CO (1) CO5640070A2 (enExample)
CY (1) CY1108137T1 (enExample)
DE (1) DE602004012718T2 (enExample)
DK (1) DK1608336T3 (enExample)
EA (1) EA009087B1 (enExample)
EC (1) ECSP056029A (enExample)
ES (1) ES2304616T3 (enExample)
HR (1) HRP20050822B1 (enExample)
ME (1) ME00420B (enExample)
MX (1) MXPA05009920A (enExample)
NO (1) NO336457B1 (enExample)
NZ (1) NZ542957A (enExample)
PL (1) PL1608336T3 (enExample)
PT (1) PT1608336E (enExample)
RS (1) RS51663B (enExample)
SI (1) SI1608336T1 (enExample)
UA (1) UA89751C2 (enExample)
WO (1) WO2004084858A2 (enExample)
ZA (1) ZA200506463B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
DK1809243T4 (da) * 2004-07-02 2022-09-05 Boehringer Ingelheim Int Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
JP5358574B2 (ja) * 2007-08-17 2013-12-04 アルション セラピューティクス, インコーポレイテッド 高濃度の局所麻酔薬調合物
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
WO2010112358A2 (de) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Verfahren zur beschichtung einer oberfläche eines bauteils
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EA033013B1 (ru) 2014-05-07 2019-08-30 Бёрингер Ингельхайм Интернациональ Гмбх Контейнер, индикаторное устройство и небулайзер
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
EP3280393A1 (en) * 2015-04-10 2018-02-14 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2021216779A1 (en) * 2020-04-21 2021-10-28 Amphastar Pharmaceuticals, Inc. Anti-viral pharmaceutical formulations administered via devices for lung targeted delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3009924B2 (ja) * 1992-12-09 2000-02-14 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 安定化医用エアーゾル溶液製剤
EP0960830A1 (en) 1993-04-30 1999-12-01 Minnesota Mining And Manufacturing Company Seal configuration for aerosol canister
AU680530B2 (en) 1993-07-15 1997-07-31 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
BR9604979A (pt) * 1995-04-14 1998-06-09 Glaxo Wellcome Inc Inalador de dose medida sistema inalador de dose medida e uso do mesmo
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
EP1414508B1 (en) 2001-06-26 2011-04-20 Norton Healthcare Limited An improved aerosol actuator

Also Published As

Publication number Publication date
WO2004084858A2 (en) 2004-10-07
DE602004012718D1 (de) 2008-05-08
AU2004224367A1 (en) 2004-10-07
MXPA05009920A (es) 2005-11-04
EA009087B1 (ru) 2007-10-26
RS20050705A (sr) 2008-04-04
RS51663B (sr) 2011-10-31
EP1608336A2 (en) 2005-12-28
KR101113003B1 (ko) 2012-02-24
KR20050111382A (ko) 2005-11-24
DE602004012718T2 (de) 2009-05-07
NO336457B1 (no) 2015-08-31
BRPI0408547A (pt) 2006-03-07
NZ542957A (en) 2008-09-26
HRP20050822A2 (en) 2006-10-31
ES2304616T3 (es) 2008-10-16
NO20054839L (no) 2005-10-19
HRP20050822B1 (hr) 2013-09-30
ME00420B (me) 2011-12-20
CA2519523C (en) 2012-03-13
CY1108137T1 (el) 2014-02-12
WO2004084858A3 (en) 2004-11-04
SI1608336T1 (sl) 2008-08-31
CA2519523A1 (en) 2004-10-07
EA200501363A1 (ru) 2006-04-28
JP2006520797A (ja) 2006-09-14
ZA200506463B (en) 2006-04-26
PT1608336E (pt) 2008-04-21
ECSP056029A (es) 2006-01-27
AU2004224367B2 (en) 2009-10-08
UA89751C2 (ru) 2010-03-10
CN1761455A (zh) 2006-04-19
JP4708332B2 (ja) 2011-06-22
US7914770B2 (en) 2011-03-29
DK1608336T3 (da) 2008-06-02
EP1608336B1 (en) 2008-03-26
CO5640070A2 (es) 2006-05-31
US20040184994A1 (en) 2004-09-23
PL1608336T3 (pl) 2008-09-30

Similar Documents

Publication Publication Date Title
ATE390125T1 (de) Formulierung für einen dosierinhalator unter verwendung von hydro-fluoro-alkanen als treibstoffe
BRPI0517493A (pt) polinucleotìdeo isolado, promotor vetor de expressão, célula hospedeira e uso de um polinucleotìdeo
DE60138404D1 (de) Verbessertes system zur regulation der transgenexpression
BRPI0412310A (pt) uso de um agente controlador de reologia, agente modificador de reologia, concentrados, e, composições com reologia melhorada
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
DE50210313D1 (de) Amphotere sterole und deren verwendung
CY1105337T1 (el) Πρωτοτυπες διυδροπτepιδινονες, μεθοδος για την παραγωγη τους και η χρηση τους ως φαρμακευτικα μεσα
TR200702139T2 (tr) Yeni bitki tanım yapıları
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
EA200700042A1 (ru) РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
DE502005006425D1 (de) N-ethylpyrrolidon in der herstellung von polyurethandispersionen
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
EA200401621A1 (ru) Модуляторы сск-1 рецепторов
ATE380208T1 (de) Isocyanatfreie schäumbare mischungen
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
ATE549351T1 (de) Chimärer peptidantagonist für gpcr135 oder gpcr142
ATE273394T1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
SE0001530D0 (sv) A reporter protein
MXPA03010613A (es) Benzoilpirazoles substituidos con actividad herbicida.
DE50109166D1 (de) Verfahren zur verbesserung der transfektionseffizienz
DK1945760T3 (da) Produktivitetsforøgende proteinfaktor, hidtil ukendte cellelinjer og anvendelser deraf
CY1105561T1 (el) Προαγωγεας για τον λειτουργικο χαρακτηρισμο υποδοχεων συζευγμενων με την πρωτεϊνη g στον ζυμομυκητα saccharomyces cerevisiae
ATE440993T1 (de) Mit calixarenen ausgerüstete textile materialien, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1608336

Country of ref document: EP